ID

28129

Description

Thalidomide and Tegafur/Uracil(UFUR) in the Treatment of Advanced Colorectal Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00890188

Link

https://clinicaltrials.gov/show/NCT00890188

Keywords

Versions (1)
  1. 12/20/17 12/20/17 -
Copyright Holder

See clinicaltrials.gov

Uploaded on

December 20, 2017

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Colon Cancer NCT00890188

English

Eligibility Colon Cancer NCT00890188

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
histologically or cytologically confirmed colorectal carcinoma
Description

Colorectal Carcinoma

Data type

boolean

Alias
UMLS CUI [1]
C0009402
patients must have received at least one oxaliplatin-contained chemotherapy before the study and did not want to receive or tolerate irinotecan- contained chemotherapy
Description

Chemotherapy Containing Oxaliplatin Quantity | Unwilling Chemotherapy Containing Irinotecan

Data type

boolean

Alias
UMLS CUI [1,1]
C0392920
UMLS CUI [1,2]
C0332256
UMLS CUI [1,3]
C0069717
UMLS CUI [1,4]
C1265611
UMLS CUI [2,1]
C0558080
UMLS CUI [2,2]
C0392920
UMLS CUI [2,3]
C0332256
UMLS CUI [2,4]
C0123931
presence of at least one measurable disease which is defined as lesion that can be measured in at least 1 dimension as 20 mm with conventional ct or 10 mm with spiral ct scan
Description

Measurable Disease Quantity | Measurement Dimensions Quantity | Measurable Disease Size CT | Measurable Disease Size Spiral CT

Data type

boolean

Alias
UMLS CUI [1,1]
C1513041
UMLS CUI [1,2]
C1265611
UMLS CUI [2,1]
C0242485
UMLS CUI [2,2]
C0439534
UMLS CUI [2,3]
C1265611
UMLS CUI [3,1]
C1513041
UMLS CUI [3,2]
C0456389
UMLS CUI [3,3]
C0040405
UMLS CUI [4,1]
C1513041
UMLS CUI [4,2]
C0456389
UMLS CUI [4,3]
C0860888
age ≥ 18 year, ecog performance status 0, 1, 2, 3
Description

Age | ECOG performance status

Data type

boolean

Alias
UMLS CUI [1]
C0001779
UMLS CUI [2]
C1520224
white blood cell (wbc) ≥ 3,000/mm3, absolute neutrophil count (anc) ≥ 1,500/mm3, platelets ≥ 100,000/mm3 and hemoglobin ≥ 8 mg / dl
Description

White Blood Cell Count procedure | Absolute neutrophil count | Platelet Count measurement | Hemoglobin measurement

Data type

boolean

Alias
UMLS CUI [1]
C0023508
UMLS CUI [2]
C0948762
UMLS CUI [3]
C0032181
UMLS CUI [4]
C0518015
serum creatinine level 2.0 mg/dl or lower
Description

Creatinine measurement, serum

Data type

boolean

Alias
UMLS CUI [1]
C0201976
serum bilirubin less than 1.5 times the upper limit of normal range (uln)
Description

Serum total bilirubin measurement

Data type

boolean

Alias
UMLS CUI [1]
C1278039
alanine aminotransferase (alt) or aspartate aminotransferase (ast) less than 2.5 times the uln if no demonstrable liver metastases or less than 5 times the uln in the presence of liver metastases
Description

Alanine aminotransferase measurement | Aspartate aminotransferase measurement | Secondary malignant neoplasm of liver

Data type

boolean

Alias
UMLS CUI [1]
C0201836
UMLS CUI [2]
C0201899
UMLS CUI [3]
C0494165
require to wait 28 days before entry onto the study after being treated with any immunotherapy, or biologic systemic (including any target therapy)
Description

Immunotherapy | Biological treatment Systemic | Targeted Therapy

Data type

boolean

Alias
UMLS CUI [1]
C0021083
UMLS CUI [2,1]
C1531518
UMLS CUI [2,2]
C0205373
UMLS CUI [3]
C2985566
written informed consent to participate in the trial
Description

Informed Consent

Data type

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
presence of cns metastasis
Description

CNS metastases

Data type

boolean

Alias
UMLS CUI [1]
C0686377
other malignancy with the exception of curative treated non-melanoma skin cancer or cervical carcinoma in situ within 5 years prior to the entry of study
Description

Cancer Other | Exception Curative treatment Skin carcinoma | Exception Curative treatment Carcinoma in situ of uterine cervix

Data type

boolean

Alias
UMLS CUI [1]
C1707251
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C1273390
UMLS CUI [2,3]
C0699893
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C1273390
UMLS CUI [3,3]
C0851140
less than 4 weeks since previous treatment
Description

Prior Therapy

Data type

boolean

Alias
UMLS CUI [1]
C1514463
concomitant illness that might be aggregated by chemotherapy. for examples, active, non-controlled infection or other active, non-controlled disease such as congestive heart failure, angina pectoris, respiratory insufficiency, arrhythmia. it depends on investigation's decision.
Description

Comorbidity | Chemotherapy | Communicable Disease Uncontrolled | Disease Uncontrolled | Congestive heart failure | Angina Pectoris | Respiratory Insufficiency | Cardiac Arrhythmia

Data type

boolean

Alias
UMLS CUI [1]
C0009488
UMLS CUI [2]
C0392920
UMLS CUI [3,1]
C0009450
UMLS CUI [3,2]
C0205318
UMLS CUI [4,1]
C0012634
UMLS CUI [4,2]
C0205318
UMLS CUI [5]
C0018802
UMLS CUI [6]
C0002962
UMLS CUI [7]
C0035229
UMLS CUI [8]
C0003811
women of child-bearing potential without using a reliable and appropriate contraceptive method during study period
Description

Childbearing Potential Contraceptive methods Lacking

Data type

boolean

Alias
UMLS CUI [1,1]
C3831118
UMLS CUI [1,2]
C0700589
UMLS CUI [1,3]
C0332268
pre existent sensory or motor neurotoxicity > grade 2 according to national cancer institute (nci) common toxicity criteria (ctc) (disabling paresthesia and/or significant motor loss)
Description

Neurotoxicity Sensory Pre-existing CTCAE Grades | Neurotoxicity Motor Pre-existing CTCAE Grades | Paresthesia Disabling condition | Loss of motor functions

Data type

boolean

Alias
UMLS CUI [1,1]
C0235032
UMLS CUI [1,2]
C0445254
UMLS CUI [1,3]
C2347662
UMLS CUI [1,4]
C1516728
UMLS CUI [2,1]
C0235032
UMLS CUI [2,2]
C0501384
UMLS CUI [2,3]
C2347662
UMLS CUI [2,4]
C1516728
UMLS CUI [3,1]
C0030554
UMLS CUI [3,2]
C4061999
UMLS CUI [4]
C1864672
patients who are receiving other concomitant chemotherapy, radiotherapy or any other investigational therapy
Description

Chemotherapy | Therapeutic radiology procedure | Therapy, Investigational

Data type

boolean

Alias
UMLS CUI [1]
C0392920
UMLS CUI [2]
C1522449
UMLS CUI [3]
C0949266
Back to the top of the page

Similar models

Eligibility Colon Cancer NCT00890188

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Colorectal Carcinoma
Item
histologically or cytologically confirmed colorectal carcinoma
boolean
C0009402 (UMLS CUI [1])
Chemotherapy Containing Oxaliplatin Quantity | Unwilling Chemotherapy Containing Irinotecan
Item
patients must have received at least one oxaliplatin-contained chemotherapy before the study and did not want to receive or tolerate irinotecan- contained chemotherapy
boolean
C0392920 (UMLS CUI [1,1])
C0332256 (UMLS CUI [1,2])
C0069717 (UMLS CUI [1,3])
C1265611 (UMLS CUI [1,4])
C0558080 (UMLS CUI [2,1])
C0392920 (UMLS CUI [2,2])
C0332256 (UMLS CUI [2,3])
C0123931 (UMLS CUI [2,4])
Measurable Disease Quantity | Measurement Dimensions Quantity | Measurable Disease Size CT | Measurable Disease Size Spiral CT
Item
presence of at least one measurable disease which is defined as lesion that can be measured in at least 1 dimension as 20 mm with conventional ct or 10 mm with spiral ct scan
boolean
C1513041 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C0242485 (UMLS CUI [2,1])
C0439534 (UMLS CUI [2,2])
C1265611 (UMLS CUI [2,3])
C1513041 (UMLS CUI [3,1])
C0456389 (UMLS CUI [3,2])
C0040405 (UMLS CUI [3,3])
C1513041 (UMLS CUI [4,1])
C0456389 (UMLS CUI [4,2])
C0860888 (UMLS CUI [4,3])
Age | ECOG performance status
Item
age ≥ 18 year, ecog performance status 0, 1, 2, 3
boolean
C0001779 (UMLS CUI [1])
C1520224 (UMLS CUI [2])
White Blood Cell Count procedure | Absolute neutrophil count | Platelet Count measurement | Hemoglobin measurement
Item
white blood cell (wbc) ≥ 3,000/mm3, absolute neutrophil count (anc) ≥ 1,500/mm3, platelets ≥ 100,000/mm3 and hemoglobin ≥ 8 mg / dl
boolean
C0023508 (UMLS CUI [1])
C0948762 (UMLS CUI [2])
C0032181 (UMLS CUI [3])
C0518015 (UMLS CUI [4])
Creatinine measurement, serum
Item
serum creatinine level 2.0 mg/dl or lower
boolean
C0201976 (UMLS CUI [1])
Serum total bilirubin measurement
Item
serum bilirubin less than 1.5 times the upper limit of normal range (uln)
boolean
C1278039 (UMLS CUI [1])
Alanine aminotransferase measurement | Aspartate aminotransferase measurement | Secondary malignant neoplasm of liver
Item
alanine aminotransferase (alt) or aspartate aminotransferase (ast) less than 2.5 times the uln if no demonstrable liver metastases or less than 5 times the uln in the presence of liver metastases
boolean
C0201836 (UMLS CUI [1])
C0201899 (UMLS CUI [2])
C0494165 (UMLS CUI [3])
Immunotherapy | Biological treatment Systemic | Targeted Therapy
Item
require to wait 28 days before entry onto the study after being treated with any immunotherapy, or biologic systemic (including any target therapy)
boolean
C0021083 (UMLS CUI [1])
C1531518 (UMLS CUI [2,1])
C0205373 (UMLS CUI [2,2])
C2985566 (UMLS CUI [3])
Informed Consent
Item
written informed consent to participate in the trial
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
CNS metastases
Item
presence of cns metastasis
boolean
C0686377 (UMLS CUI [1])
Cancer Other | Exception Curative treatment Skin carcinoma | Exception Curative treatment Carcinoma in situ of uterine cervix
Item
other malignancy with the exception of curative treated non-melanoma skin cancer or cervical carcinoma in situ within 5 years prior to the entry of study
boolean
C1707251 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C1273390 (UMLS CUI [2,2])
C0699893 (UMLS CUI [2,3])
C1705847 (UMLS CUI [3,1])
C1273390 (UMLS CUI [3,2])
C0851140 (UMLS CUI [3,3])
Prior Therapy
Item
less than 4 weeks since previous treatment
boolean
C1514463 (UMLS CUI [1])
Comorbidity | Chemotherapy | Communicable Disease Uncontrolled | Disease Uncontrolled | Congestive heart failure | Angina Pectoris | Respiratory Insufficiency | Cardiac Arrhythmia
Item
concomitant illness that might be aggregated by chemotherapy. for examples, active, non-controlled infection or other active, non-controlled disease such as congestive heart failure, angina pectoris, respiratory insufficiency, arrhythmia. it depends on investigation's decision.
boolean
C0009488 (UMLS CUI [1])
C0392920 (UMLS CUI [2])
C0009450 (UMLS CUI [3,1])
C0205318 (UMLS CUI [3,2])
C0012634 (UMLS CUI [4,1])
C0205318 (UMLS CUI [4,2])
C0018802 (UMLS CUI [5])
C0002962 (UMLS CUI [6])
C0035229 (UMLS CUI [7])
C0003811 (UMLS CUI [8])
Childbearing Potential Contraceptive methods Lacking
Item
women of child-bearing potential without using a reliable and appropriate contraceptive method during study period
boolean
C3831118 (UMLS CUI [1,1])
C0700589 (UMLS CUI [1,2])
C0332268 (UMLS CUI [1,3])
Neurotoxicity Sensory Pre-existing CTCAE Grades | Neurotoxicity Motor Pre-existing CTCAE Grades | Paresthesia Disabling condition | Loss of motor functions
Item
pre existent sensory or motor neurotoxicity > grade 2 according to national cancer institute (nci) common toxicity criteria (ctc) (disabling paresthesia and/or significant motor loss)
boolean
C0235032 (UMLS CUI [1,1])
C0445254 (UMLS CUI [1,2])
C2347662 (UMLS CUI [1,3])
C1516728 (UMLS CUI [1,4])
C0235032 (UMLS CUI [2,1])
C0501384 (UMLS CUI [2,2])
C2347662 (UMLS CUI [2,3])
C1516728 (UMLS CUI [2,4])
C0030554 (UMLS CUI [3,1])
C4061999 (UMLS CUI [3,2])
C1864672 (UMLS CUI [4])
Chemotherapy | Therapeutic radiology procedure | Therapy, Investigational
Item
patients who are receiving other concomitant chemotherapy, radiotherapy or any other investigational therapy
boolean
C0392920 (UMLS CUI [1])
C1522449 (UMLS CUI [2])
C0949266 (UMLS CUI [3])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial